# Joy Faucher

> Joy Faucher is a Series A investor at Forbion Capital Partners backing Biotechnology and Farming. See 4 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Forbion Capital Partners](https://shizune.co/investors/profile/forbion-capital-partners)
- Location: Naarden, The Netherlands
- Total investments: 4
- Last investment: Mar 2026
- Lead investor: 75%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/joyfaucher/?originalSubdomain=nl

Joy Faucher is a Series A investor at Forbion Capital Partners in Naarden focused on Biotechnology and Farming. Joy Faucher is based out of Naarden, Noord-Holland and is the General Partner at Forbion Capital Partners. He graduated from the University of Cambridge.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 4 | 100% |
| Farming | 1 | 25% |
| Agriculture | 1 | 25% |
| Sustainability | 1 | 25% |
| Food and Beverage | 1 | 25% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 2 | 50% |
| Pre-Seed | 1 | 25% |
| Series C | 1 | 25% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United Kingdom | 3 | 75% |
| The Netherlands | 1 | 25% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Tropic Biosciences | At Tropic Biosciences, They develop high-performing commercial varieties of tropical crops which promote grower wellbeing, consumer health, and improved sustainable environmental practices, using cutting edge non-GMO gene editing techniques. | $105M | Series C | Mar 12, 2026 |  |
| PACT | PACT designs Elegant materials produced in tune with the planet earth. It create revolutionary, sustainable biomaterials using the earth's resources, including collagen, herbal extracts, oils, and minerals. | $21.1M | Series A | Oct 30, 2025 |  |
| Solasta Bio | Solasta Bio develops environment-friendly products that meet a global need for new and effective crop protection. | $14M | Series A | Sep 11, 2024 |  |
| Farmless | A farmless fermentation platform has the potential to create an entirely new food repertoire, producing proteins, carbohydrates, beneficial fats, vitamins, and minerals from the ground up," explained Oner. "We are creating a new interface between food and electricity by domesticating microbes chosen for their food properties and abilityto grow on renewable energy-based feedstocks. | $1.3M | Pre-Seed | May 10, 2023 |  |

4 of 4 investments shown.

## Co-investors
- [Scottish Enterprise](https://shizune.co/investors/profile/scottish-enterprise) — VC Fund, 2 deals together
- [Genoa Ventures](https://shizune.co/investors/profile/5-prime-ventures) — VC Fund, 1 deal together
- [Aliment Capital](https://shizune.co/investors/profile/aliment-capital) — VC Fund, 1 deal together
- [Cavallo Ventures](https://shizune.co/investors/profile/cavallo-ventures) — VC Fund, 1 deal together
- [Corteva Agriscience](https://shizune.co/investors/profile/corteva-agriscience) — VC Fund, 1 deal together
- [Corteva Catalyst](https://shizune.co/investors/profile/corteva-catalyst) — VC Fund, 1 deal together

## About Forbion Capital Partners

VC Fund · Naarden, The Netherlands

Forbion Capital Partners is a Netherlands-based venture capital firm focused on investing in life sciences companies in drug development as well as MedTech companies addressing high medical needs. Forbion's investment team of nine investment professionals has built an impressive performance track record since the late nineties with successfulinvestments in Rhein Biotech, Crucell, Neutec, Glycart, Borean, Impella, Alantos, Acorda, Fovea and PanGenetics. Current assets under management exceed â‚¬400m ($500m), split between three active funds. Finally, Forbion co-manages BioGeneration Ventures, an early stage fund focused on academic spin-outs and seed investments in the Netherlands.

5 contacts available at Forbion Capital Partners.

| Name | Title | Profile |
| --- | --- | --- |
| Joy Faucher | General Partner | https://shizune.co/investors/profile/joy-faucher-c13e |
| Marco Boorsma | General Partner | https://shizune.co/investors/profile/marco-boorsma |
| Nanna Lüneborg | General Partner | https://shizune.co/investors/profile/nanna-lneborg |
| Onno Stolpe | Venture Partner | https://shizune.co/investors/profile/onno-van-de-stolpe |
| Sander Slootweg | Managing Partner and co-founder | https://shizune.co/investors/profile/sander-slootweg |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Joy Faucher invest in?

Joy Faucher invests primarily in Biotechnology, Farming and Agriculture startups, most often at Series A and Pre-Seed stage. Most of the 4 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Joy Faucher last invest?

The most recent investment recorded for Joy Faucher closed in Mar 2026. Shizune tracks 4 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co
